Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Jiri, Suttnar"'
Autor:
Pavel Burda, Alzbeta Hlavackova, Vendula Polivkova, Nikola Curik, Adam Laznicka, Jitka Krizkova, Jiri Suttnar, Pavel Klener, Katerina Machova Polakova
Publikováno v:
Molecular Metabolism, Vol 88, Iss , Pp 102016- (2024)
Objective: A prominent, safe and efficient therapy for patients with chronic myeloid leukemia (CML) is inhibiting oncogenic protein BCR::ABL1 in a targeted manner with imatinib, a tyrosine kinase inhibitor. A substantial part of patients treated with
Externí odkaz:
https://doaj.org/article/5291343c15e94e9fb1424c43740d28fb
Autor:
Jirina Kaufmanova, Jana Stikarova, Alzbeta Hlavackova, Leona Chrastinova, Martin Maly, Jiri Suttnar, Jan Evangelista Dyr
Publikováno v:
Antioxidants, Vol 10, Iss 6, p 923 (2021)
During coagulation, the soluble fibrinogen is converted into insoluble fibrin. Fibrinogen is a multifunctional plasma protein, which is essential for hemostasis. Various oxidative posttranslational modifications influence fibrinogen structure as well
Externí odkaz:
https://doaj.org/article/f2fe94ed175a4b309c2abdd591a4a159
Publikováno v:
Metabolites, Vol 11, Iss 5, p 307 (2021)
Fibrinogen is an abundant blood plasma protein that, inter alia, participates in blood coagulation. It polymerizes to form a fibrin clot that is among the major components of the thrombus. Fibrinogen reactions with various reactive metabolites may in
Externí odkaz:
https://doaj.org/article/85a5c0b4f9084fce85c8fa524700afa1
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 132, p 132 (2022)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Fibrinogen, an abundant plasma glycoprotein, is involved in the final stage of blood coagulation. Decreased fibrinogen levels, which may be caused by mutations, are manifested mainly in bleeding and thrombotic disorders. Clinically relevant mutations
Autor:
Martin Hajsl, Alzbeta Hlavackova, Karolina Broulikova, Martin Sramek, Martin Maly, Jan E. Dyr, Jiri Suttnar
Publikováno v:
Metabolites, Vol 10, Iss 5, p 208 (2020)
Atherosclerosis is a leading cause of major vascular events, myocardial infarction, and ischemic stroke. Tryptophan (TRP) catabolism was recognized as an important player in inflammation and immune response having together with oxidative stress (OS)
Externí odkaz:
https://doaj.org/article/b1bb9d730fd34a5583d28faa8b43987c
Autor:
Lucie Himmlova, Dana Kubies, Hana Hulejova, Jirina Bartova, Tomas Riedel, Jana Stikarova, Jiri Suttnar, Vlasta Pesakova
Publikováno v:
Mediators of Inflammation, Vol 2016 (2016)
The study monitored in vitro early response of connective tissue cells and immunocompetent cells to enosseal implant materials coated by different blood components (serum, activated plasma, and plasma/platelets) to evaluate human osteoblast prolifera
Externí odkaz:
https://doaj.org/article/76f7dc76c9454f9d98dcc3161c78905f
Autor:
Martin Hajšl, Ondrej Kucerka, Jan E. Dyr, Petr Tousek, John W. Weisel, Jirina Kaufmanova, Martin Maly, Jiri Suttnar, Jana Štikarová, Roman Kotlín, Tomáš Riedel
Publikováno v:
Thrombosis and haemostasis. 122(3)
We describe the internal structure, spatial organization and dynamic formation of coronary artery thrombi from ST-segment elevation myocardial infarction patients. Scanning electron microscopy (SEM) revealed significant differences among four groups
Autor:
Alzbeta Hlavackova, Jan Vydra, Leona Chrastinova, Eliska Ceznerova, Marek Havlicek, Jana Stikarova, Roman Kotlin, Jiri Suttnar
Publikováno v:
Blood. 140:11833-11833
Autor:
Eliska Ceznerova, Jirina Kaufmanova, Marek Havlicek, Ondrej Pastva, Alzbeta Hlavackova, Roman Kotlin, Jiri Suttnar
Publikováno v:
Blood. 140:2719-2719
Publikováno v:
Metabolites
Volume 11
Issue 5
Metabolites, Vol 11, Iss 307, p 307 (2021)
Volume 11
Issue 5
Metabolites, Vol 11, Iss 307, p 307 (2021)
Fibrinogen is an abundant blood plasma protein that, inter alia, participates in blood coagulation. It polymerizes to form a fibrin clot that is among the major components of the thrombus. Fibrinogen reactions with various reactive metabolites may in